SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,549,000 | +60.1% | 450,000 | +51.3% | 2.20% | +84.6% |
Q2 2023 | $34,069,700 | -40.6% | 297,500 | -28.5% | 1.19% | -37.5% |
Q1 2023 | $57,337,280 | -58.1% | 416,000 | -60.6% | 1.90% | -35.8% |
Q4 2022 | $136,706,900 | +30.4% | 1,055,000 | +11.3% | 2.96% | +39.0% |
Q3 2022 | $104,814,000 | +182.8% | 948,200 | +336.2% | 2.13% | +77.1% |
Q4 2020 | $37,065,000 | +373.6% | 217,400 | +171.8% | 1.20% | +11.2% |
Q1 2020 | $7,826,000 | – | 80,000 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |